About: Considerations on the Restriction of Assisted Reproductive Technology (ART)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Considerations on the Restriction of Assisted Reproductive Technology (ART) Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Considerations on the Restriction of Assisted Reproductive Technology (ART)
Creator	Williams, Zev Forman, Eric Gemmell, Laura
Source	Elsevier; PMC
abstract	The rapid rise of novel coronavirus disease 2019 (COVID-19) cases led the American Society for Reproductive Medicine (ASRM) to recommend immediate cessation of all new fertility treatment cycles on March 17, 2020. Controversial from the start, providers and patients expressed their opposition through online petitions, surveys, and other forums. While the impact of a delay in access to reproductive care is unknown, previous studies are reassuring that a delay in the timespan of months may not affect clinical outcomes. However, dropout from care during this pandemic remains a serious concern. Effective therapies against the virus and a vaccine are not on the immediate horizon. Accepting COVID-19 will likely be a part of our lives for the foreseeable future necessitates the modification of fertility protocols to keep patients, providers, and staff as safe as possible. We believe fertility treatment is an urgent, essential service that can be performed safely and responsibly during this pandemic.
has issue date	2020-08-27(xsd:dateTime)
bibo:doi	10.1016/j.semperi.2020.151288
has license	no-cc
sha1sum (hex)	141797707a3065288fb18fb94b103ddfbf1367c8
schema:url	https://doi.org/10.1016/j.semperi.2020.151288
resource representing a document's title	Considerations on the Restriction of Assisted Reproductive Technology (ART)
has PubMed Central identifier	PMC7450235
schema:publication	Semin Perinatol
resource representing a document's body	covid:141797707a3065288fb18fb94b103ddfbf1367c8#body_text
is schema:about of	named entity 'responsibly' named entity 'coronavirus disease 2019' named entity 'cases' named entity 'start' named entity 'affect' named entity 'expressed' named entity 'IMPACT' named entity 'FERTILITY' covid:arg/141797707a3065288fb18fb94b103ddfbf1367c8 named entity 'protocols' named entity 'fertility treatment' named entity 'Reproductive Medicine' named entity 'Columbia University Irving Medical Center' named entity 'LMP' named entity 'IVF' named entity 'live birth' named entity 'pregnancy' named entity 'RCT' named entity 'reproductive medicine' named entity 'IUI' named entity 'liquid nitrogen' named entity 'egg retrieval' named entity 'Pregnancy' named entity 'live births' named entity 'fertility clinic' named entity 'March 1' named entity 'ASRM' named entity 'reproductive endocrinologist' named entity 'sperm production' named entity 'menstrual period' named entity 'New York City' named entity 'follow-up' named entity 'fertility treatment' named entity 'methotrexate' named entity 'male factor infertility' named entity 'COVID-19' named entity 'IVF' named entity 'fertility' named entity 'opposition' named entity 'Journal' named entity 'fertility' named entity 'ASRM' named entity 'fertility treatment' named entity 'vaccine' named entity 'reproductive care' named entity 'coronavirus disease 2019' named entity 'March 17' named entity 'COVID-19' named entity 'fetal' named entity 'non-maleficence' named entity 'ultrasound' named entity 'IVF' named entity 'Fertility clinics' named entity 'Sperm production' named entity 'state of emergency' named entity 'Telemedicine' named entity 'birth control' named entity 'follicle stimulating hormone' named entity 'American College of Obstetricians and Gynecologists' named entity 'loss of smell' named entity 'ASRM' named entity 'cross contamination' named entity 'live births' named entity 'United States' named entity 'afebrile' named entity 'health service' named entity 'ovarian reserve' named entity 'pregnancy rates' named entity 'ultrasound' named entity 'viruses' named entity 'disease transmission' named entity 'clomiphene citrate' named entity 'chemotherapy' named entity 'social distancing' named entity 'cough' named entity 'March 17' named entity 'asymptomatic' named entity 'PCR' named entity 'surgical management' named entity 'New York' named entity 'ASRM'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software